1 Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom; Department of Microbiology, Liverpool Clinical Laboratories, Liverpool University National Health Service Foundation Trust, Liverpool, United Kingdom; Blizard Institute, Queen Mary University of London, London, United Kingdom.
2 Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.
3 Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom; Department of Microbiology, Liverpool Clinical Laboratories, Liverpool University National Health Service Foundation Trust, Liverpool, United Kingdom.
4 Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom; Infection Clinical Academic Group, St. George's University Hospital National Health Service Foundation Trust, London, United Kingdom; National Institute for Healthcare Research Health Protection Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom.
5 Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom; Department of Microbiology, Liverpool Clinical Laboratories, Liverpool University National Health Service Foundation Trust, Liverpool, United Kingdom. Electronic address: cdarlow@liverpool.ac.uk.